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Enhanced Recovery (ER) after Surgery (or Fast Track) is a
bundle of ‘best evidence based practices’ delivered by a
multi-professional health care team, with the intention of
helping patients recover faster after surgery [1]. Professor
Henrik Kehlet, a surgeon from Denmark, pioneered the
concept more than a decade ago but practitioners in the
UK remained sceptical of his amazing results and adoption
in the National Health Service (NHS) had been slow [1,2].
The Enhanced Recovery Partnership Programme (ERPP)
was set up by the Department of Health in England in May
2009, to encourage the widespread adoption of ER with
the aim of improving recovery from major surgery [1,3].
The Programme initially concentrated on elective major
surgery in four specialities (Colorectal, Musculoskeletal,
Gynaecology and Urology). Audit of ER practice by the
early adopters demonstrated greater than 80% compliance
with the majority of elements recommended by the ERPP.
However, perioperative fluid management including the
administration of pre-operative carbohydrate drinks and
individualised goal directed fluid management guided by
advanced haemodynamic monitoring (e.g. Oesophageal
Doppler) had lower levels of compliance [3]. A pilot
study using Commissioning for Quality and Innovation
(CQUIN) to encourage practice change showed a dramatic
improvement in outcomes in North Central London with
very high levels of compliance with the ERPP recom-
mended principles of perioperative fluid management, in
particular goal directed fluid management [4].
The National Programme has evolved into the Enhanced
Recovery Partnership (ERP), and the most recent guide
published by the ERP includes evidence of widespread
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reproduction in any medium, provided the orstated goals i.e. reduced length of hospital stay after sur-
gery resulting in more operations being performed despite
fewer bed days, no increase in readmissions and high levels
of patient satisfaction [5]. Perioperative fluid manage-
ment is at the heart of Enhanced Recovery and the use
of intra-operative fluid management technology, such as
Oesophageal Doppler, is supported by the ERP in line
with the National Institute of Clinical Excellence (NICE)
Guidance (MTG3), the NHS Operating Framework
2012–13 and the Department of Health Innovation
Health and Wealth Review 2011 [5-7]. Despite concord-
ance in the guidelines, the veracity of the evidence has
been challenged [8,9].
The ERP thought it was timely to produce a consensus
statement from the National Clinical Leads and Specialist
Advisors within the specific context of Enhanced Recovery
and, for the purpose of widespread dissemination, the
general principles and key recommendations outlined in
the latest guide are reiterated in this article [5]. Of note, no
particular evidence based methodology was used aside
from seeking unanimous agreement from the authors. A
practical and pragmatic set of guidelines and recommenda-
tions was the aim. The conclusions do align with the GIF-
TASUP guidelines and NICE guidance where established
EBM methodologies were utilised [6,8,10]. In making this
consensus statement we agree that larger, more definitive
studies of perioperative fluid management and, in particu-
lar, the relative contribution of haemodynamic monitoring
compared with fluid restriction would be welcomed
[11,12]. However, to be useful, such studies must be con-
ducted in the context of a fully implemented Enhanced
Recovery Program.General principles of enhanced recovery fluid
management and recommendations of the
enhanced recovery partnership
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 Maintain good pre-operative hydration.
 Give carbohydrate drinks.
 Avoid bowel preparation.
Peri-operative
 Use fluid management technologies to deliver
individualised goal directed fluid therapy.
 Avoid crystalloid excess (salt and water overload).
‘Maintenance’ fluid, if utilised, should be limited to
less than 2 ml/kg/hr including any drug infusions.
The use of isotonic balanced electrolyte solution
(e.g. Hartmann’s) will minimise hyperchloraemic
acidosis.
Post-operative
 Avoid post-operative i.v. fluids when it is possible.
 Always ask the question; ‘what are we giving fluids for?:
∘Maintenance fluid? -Push early drinking and eating;
∘Replacement fluid? -Consider oral before i.v. and
consider ‘prescribing’ oral fluids
∘Resuscitation fluids? -Use Goal Directed Fluid
Therapy
The Enhanced Recovery Partnership recommends
the development of local guidelines and algorithms
for fluid management and regular audit of
compliance, in line with national guidelines, NICE
recommendations and the Innovation, Health and
Wealth Review (2011) [6,8].
Aims of ER fluid management (by the end of
surgery)
 Patients core temperature is normal (circa 37°C).
 No evidence of hypovolaemia, tissue hypoperfusion
or hypoxia.
 No evidence of hypervolaemia or excess fluid (‘zero
balance’).
 Hb> 7 g/dl.
 No clinically significant coagulopathy.
 Minimal use of vasopressors.
Predictors of poor outcome include: greater age, higher
ASA status, high blood loss, longer than expected surgery,
evidence of hypovolaemia or hypoperfusion (e.g. metabo-
lic acidosis, blood lactate> 2 mmol/litre, central venous
O2< 70%), greater use of vasopressors, high volumes of
i.v. fluids (> 3.5 litres total), positive fluid balance (> 2
litres positive on day of surgery) [13-18].In an individual patient, failure to achieve these aims
should prompt a review of the need for ongoing care in
a higher care environment (e.g. extended recovery, HDU
or ITU). If audit of a group of patients shows that these
aims were not achieved, this suggests that the delivery of
care should be reviewed.
Individualized goal directed fluid therapy
The Enhanced Recovery Partnership recommends the
use of intra-operative fluid management technologies
to enhance treatment with the aim of avoiding both
hypovolaemia and fluid excess. This should be
decided on a case-by-case basis adhering to local
guidelines in the context of NICE recommendations,
national guidelines and the Innovation, Health and
Wealth Review [6,8].
Indicators of central hypovolaemia include:





 Low cardiac output
 Reduced stroke volume
 Pulse pressure variation (during IPPV)
 Pre-load responsiveness
 Low central venous O2 saturation
 Raised blood lactate
Central hypovolaemia should respond to volume ther-
apy (i.e. a fluid bolus) [13-18].
The Enhanced Recovery Partnership recommends
that all Anaesthetists caring for patients undergoing
intermediate or major surgery should have cardiac out-
put measuring technologies immediately available and
be trained to use them.
The use of intra-operative fluid management technologies
are recommended from the outset in the following types of
cases:
 Major surgery with a 30 day mortality rate of> 1%.
 Major surgery with and anticipated blood loss of
greater than 500 ml.
 Major intra-abdominal surgery.
 Intermediate surgery (30 day mortality> 0.5%) in
high risk patients (age> 80 years, history of LVF, MI,
CVA or peripheral arterial disease).
 Unexpected blood loss and/or fluid loss
requiring> 2 litres of fluid replacement.
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or tissue hypoperfusion (e.g. persistent lactic acidosis).
Perceived lack of resources is not a viable excuse.
NICE have concluded that we can’t afford NOT to use
intra-operative fluid management technologies where
indicated [6]. Practitioners should not be constrained by
lack of availability of such technology.
What NICE said about cardio-Q Doppler
“. . .The case for adopting the CardioQ-ODM in the
NHS,. . .is supported by the evidence. . .The CardioQ-
ODM should be considered for use in patients
undergoing major or high-risk surgery or other surgical
patients in whom a clinician would consider using
invasive cardiovascular monitoring. This will include
patients undergoing major or high-risk surgery or high-
risk patients undergoing intermediate-risk surgery.” [6]
The GIFTASUP guidelines said
“In patients undergoing some forms of orthopaedic and
abdominal surgery, intraoperative treatment with
intravenous fluid to achieve an optimal value of stroke
volume should be used where possible as this may
reduce postoperative complication rates and duration of
hospital stay.” [10]
What the 2010 ER implementation guide:
Delivering enhanced recovery said
“Individualised goal-directed fluid therapy. . .
When intravenous fluid is given, the benefits of
maintaining circulatory filling and organ perfusion must
be weighed against the risk of excess fluid accumulation
in the lungs causing hypoxia, and, in the gut, causing
nausea and delayed return of gut motility (ileus).
When there is not enough fluid in the bloodstream, the
stroke volume falls – that is, there is a fall in the
volume of blood ejected by the heart each heartbeat. . ..
In a typical regime enough colloid is given to maintain
the stroke volume, but no more. This allows circulatory
volume and organ perfusion to be maintained with the
minimum of administered fluid, which minimises fluid
accumulation in the tissues.” [1]
The Enhanced Recovery Partnership recommends
the regular audit of practice and outcomes bench-
marked against national data for surgical procedures.
This should ideally include:
 30 and 90 day mortality rate (ideally risk adjusted).
 Length of hospital stay. Same day admission rate.
 Readmission rate.
 Patient reported outcomes.
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